Human Metabolome Technologies (TSE:6090) EV-to-FCF: (As of Jul. 12, 2026)

Human Metabolome Technologies  (TSE:6090) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Human Metabolome Technologies's PE Ratio (TTM) for today is calculated as:

Human Metabolome Technologies's share price for today is 円598.00.
Human Metabolome Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-3.350.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Human Metabolome Technologies EV-to-FCF Related Terms

The historical data trend for Human Metabolome Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies EV-to-FCF Chart

Human Metabolome Technologies Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Jun20	Jun21	Jun22	Jun23	Jun24
EV-to-FCF		Get a 7-Day Free Trial					41.67	-64.65	17.06	17.81	10.74

Human Metabolome Technologies Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EV-to-FCF	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

TSE:6090 vs TMO, DHR, IDXX: EV-to-FCF Comparison

For the Diagnostics & Research subindustry, Human Metabolome Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Human Metabolome Technologies EV-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Human Metabolome Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Human Metabolome Technologies's EV-to-FCF falls into.

Human Metabolome Technologies EV-to-FCF Calculation

Human Metabolome Technologies's EV-to-FCF for today is calculated as:

Human Metabolome Technologies's current Enterprise Value is 円1,890.0 Mil.
Human Metabolome Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Business Description